Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by PharmAla Biotech PharmAla Launches MDMA Clinical Trial Tool for Researchers August 22, 2024 From PharmAla Biotech Via GlobeNewswire Tickers CSE:MDMA MDXXF PharmAla Comments on USFDA Decision regarding MDMA-Assisted Therapy and Announces Patent Granting for ALA-002 August 09, 2024 From PharmAla Biotech Via GlobeNewswire Tickers CSE:MDMA MDXXF Cortexa Commences Manufacturing GMP LaNeo™ MDMA in Australia April 05, 2024 From PharmAla Biotech Via GlobeNewswire Tickers CSE:MDMA MDXXF Patent Allowance Granted for ALA-002 Composition by US Patent and Trademark Office March 27, 2024 From PharmAla Biotech Via GlobeNewswire Tickers CSE:MDMA MDXXF Patent Allowance Granted for P-1 Molecule by US Patent and Trademark Office March 20, 2024 From PharmAla Biotech Via GlobeNewswire Tickers CSE:MDMA MDXXF Cortexa Leads the World in First Supply of Psilocybin Under the TGA’s Authorized Prescriber Scheme March 18, 2024 From PharmAla Biotech Via GlobeNewswire Tickers CSE:MDMA MDXXF PharmAla receives new “MDXXF” ticker from FINRA for OTCQB Listing January 24, 2024 From PharmAla Biotech Via GlobeNewswire Tickers CSE:MDMA PharmAla-1 Molecule Receives US Patent Prosecution Highway Acceptance January 08, 2024 From PharmAla Biotech Via GlobeNewswire Tickers CSE:MDMA PMBHF PharmAla Begins Trading on OTCQB September 06, 2023 From PharmAla Biotech Via GlobeNewswire Tickers CSE:MDMA PMBHF PharmAla Files Patent for Novel MDXX Molecule PharmAla-1 July 31, 2023 From PharmAla Biotech Via GlobeNewswire Tickers CSE:MDMA PMBHF USFDA Approves LaNeo MDMA for Clinical Trial Use in the United States June 09, 2023 From PharmAla Biotech Via GlobeNewswire Tickers CSE:MDMA PMBHF PharmAla Biotech to form Australian Psychedelics Joint Venture with Vitura Health May 01, 2023 From PharmAla Biotech Via GlobeNewswire Tickers ASX:VIT CSE:MDMA Australia Allows Prescription of MDMA and Psilocybin in Groundbreaking Regulatory Change February 03, 2023 From PharmAla Biotech Via GlobeNewswire Tickers CSE:MDMA Mindset Pharma and PharmAla Biotech Enter into Exclusive Sales Agreement November 16, 2022 From PharmAla Biotech Via GlobeNewswire Tickers CSE:MDMA CSE:MSET MSSTF Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.